UNDERWRITING

(ix)

the Company withdraws this prospectus (and/or any other documents issued or
used in connection with the Global Offering) or the Global Offering; or

(x)

there is a prohibition by a competent authority on the Company for whatever
reason from offering, allotting, issuing or selling any of the Offer Shares
pursuant to the terms of the Global Offering.

Undertakings to the Stock Exchange pursuant to the Listing Rules

(A) Undertakings by the Company

Pursuant to Rule 10.08 of the Listing Rules, the Company has undertaken to the Stock
it will not exercise its power to issue any further Shares, or securities
Exchange that
convertible into equity securities of the Company (whether or not of a class already listed) or
enter into any agreement to such an issue within six months from the Listing Date (whether or
not such issue of Shares or securities will be completed within six months from the Listing
Date), except (a) pursuant to the Global Offering and the Over-allotment Option or (b) under
any of the circumstances provided under Rule 10.08 of the Listing Rules.

Undertakings pursuant to the Hong Kong Underwriting Agreement

(A) Undertakings by the Company

The Company has undertaken to each of the Hong Kong Underwriters, the Joint Global
Coordinators, the Joint Bookrunners, the Joint Lead Managers and the Joint Sponsors not to
and to procure each other member of the Group not to, without the prior written consent of the
Joint Sponsors (on behalf of the Joint Global Coordinators and Hong Kong Underwriters) and
unless in compliance with the requirements of the Listing Rules, at any time during the period
commencing on the date of the Hong Kong Underwriting Agreement and ending on, and
including, the date that is six months after the Listing Date (the “First Six-Month Period”):

(i)

to allot,

issue, sell, accept subscription for, contract

offer, allot,
issue or sell,
contract or agree to allot, issue or sell, assign, grant or sell any option, warrant, right
or contract to purchase, purchase any option or contract to sell, grant or agree to
grant any option, right or warrant to purchase or subscribe for, or otherwise transfer
or dispose of or create an encumbrance over, or agree to transfer or dispose of or
create an encumbrance over, either directly or
indirectly, conditionally or
unconditionally, or repurchase, any legal or beneficial interest in any Shares or other
securities of the Company, or any Shares or other securities of such other member
of the Group, as applicable, or any interests in any of the foregoing (including, but
not limited to, any securities that are convertible into or exercisable or exchangeable
for, or that represent the right to receive, or any warrants or other rights to purchase,
any Shares or other securities of such other member of the Group, as applicable) or
deposit any Shares or other securities of the Company or any Shares or other
securities of such other member of the Group, as applicable with a depositary in
connection with the issue of depositary receipts;

– 389 –

